These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15519421)

  • 1. Holographic QSAR of selected esters.
    Chen D; Yin C; Wang X; Wang L
    Chemosphere; 2004 Dec; 57(11):1739-45. PubMed ID: 15519421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Holographic quantitative structure-activity relationship for prediction acute toxicity of benzene derivatives to the guppy (Poecilia reticulata).
    Huang H; Wang XD; Dai XL; Yu YJ; Wang LS
    J Environ Sci (China); 2004; 16(3):423-7. PubMed ID: 15272716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hologram quantitative structure activity relationship studies on 5-HT6 antagonists.
    Doddareddy MR; Lee YJ; Cho YS; Choi KI; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Jul; 12(14):3815-24. PubMed ID: 15210148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on two types of PTP1B inhibitors for the treatment of type 2 diabetes: Hologram QSAR for OBA and BBB analogues.
    Cheng Y; Zhou M; Tung CH; Ji M; Zhang F
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3329-37. PubMed ID: 20452766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D- and 3D-QSAR studies on 54 anti-tumor Rubiaceae-type cyclopeptides.
    Yan H; Pan X; Tan N; Fan J; Zeng G; Han H
    Eur J Med Chem; 2009 Sep; 44(9):3425-32. PubMed ID: 19303172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the structural and topological requirements for CCR2 antagonism: holographic QSAR for indolopiperidine derivatives.
    Srikanth K; Nair PC; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1450-6. PubMed ID: 18226895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSTR with extended topochemical atom (ETA) indices. 12. QSAR for the toxicity of diverse aromatic compounds to Tetrahymena pyriformis using chemometric tools.
    Roy K; Ghosh G
    Chemosphere; 2009 Nov; 77(7):999-1009. PubMed ID: 19709717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophilicity as a possible descriptor for toxicity prediction.
    Roy DR; Parthasarathi R; Maiti B; Subramanian V; Chattaraj PK
    Bioorg Med Chem; 2005 May; 13(10):3405-12. PubMed ID: 15848752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMACC: interpretable correlation descriptors for quantitative structure-activity relationships.
    Melville JL; Hirst JD
    J Chem Inf Model; 2007; 47(2):626-34. PubMed ID: 17381177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-toxicity relationships for the effects to Tetrahymena pyriformis of aliphatic, carbonyl-containing, alpha,beta-unsaturated chemicals.
    Schultz TW; Netzeva TI; Roberts DW; Cronin MT
    Chem Res Toxicol; 2005 Feb; 18(2):330-41. PubMed ID: 15720140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of quantitative structure-activity relationship methods based on gallic acid derivatives.
    Huang H; Ou W; Zhao J; Chen D; Wang L
    SAR QSAR Environ Res; 2004 Apr; 15(2):83-99. PubMed ID: 15199945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.
    Nair PC; Srikanth K; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1323-30. PubMed ID: 18258426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
    Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
    J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranking of aquatic toxicity of esters modelled by QSAR.
    Papa E; Battaini F; Gramatica P
    Chemosphere; 2005 Feb; 58(5):559-70. PubMed ID: 15620749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSTR with extended topochemical atom (ETA) indices. 14. QSAR modeling of toxicity of aromatic aldehydes to Tetrahymena pyriformis.
    Roy K; Das RN
    J Hazard Mater; 2010 Nov; 183(1-3):913-22. PubMed ID: 20739120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.